| OLUTASIDENIB | None | ||
| 150MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| REZLIDHIA is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test. | |||
|
Yes
| |||
| REZLIDHIA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||
| *******-*(**)-*** *********** *********** ** ******-********** ************* ********** | *******-*(**)-*** *********** *********** ** ******-********** ************* ********** | ***** ***** ** ((*)-*-((*-(*-******-*-***-*,*-***************-*-**)*****)*****)-*-******-*-***-*,*-***************-*-************ | *******-*(**)-*** *********** *********** ** ******-********** ************* ********** | ***** ***** ** ((*)-*-((*-(*-******-*-***-*,*-***************-*-**)*****)*****)-*-******-*-***-*,*-***************-*-************ | ********** ****** ********** ************* * (****-*) | ******** ******** ********* ** ********** *************-* (***-*) ******** | ********** ****** ***-* | ******** ******** ********* ** ********** ************* * (***-*) ******** | *******-*(**)-*** *********** *********** ** ******-********** ************* ********** | ***** ***** ** ((*)-*-((*-(*-******-*-***-*,*-***************-*-**)*****)*****)-*-******-*-***-*,*-***************-*-************ | ********** ****** ********** ************* * (****-*) | ***** ***** ** ((*)-*-((*-(*-******-*-***-*,*-***************-*-**)*****)*****)-*-******-*-***-*,*-***************-*-************ | *******-*(**)-*** *********** *********** ** ******-********** ************* ********** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|